Synapse

← The Lancet Regional Health - Europe

Papers in The Lancet Regional Health - Europe

Page 13 · newest first

  1. Current and future role of MRI in the diagnosis and prognosis of multiple sclerosisThe Lancet Regional Health - Europe · 2024
  2. Fluid biomarkers in multiple sclerosis: from current to future applicationsThe Lancet Regional Health - Europe · 2024
  3. Multiple sclerosis: emerging epidemiological trends and redefining the clinical courseThe Lancet Regional Health - Europe · 2024
  4. Emerging trends and challenges in multiple sclerosis in Europe: rethinking classification and addressing COVID-19 impactThe Lancet Regional Health - Europe · 2024
  5. COVID-19 and multiple sclerosis: challenges and lessons for patient careThe Lancet Regional Health - Europe · 2024
  6. COVID-19 diagnosis, vaccination during pregnancy, and adverse pregnancy outcomes of 865,654 women in England and Wales: a population-based cohort studyThe Lancet Regional Health - Europe · 2024
  7. Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort studyThe Lancet Regional Health - Europe · 2024
  8. Reproductive tract complication risks following Chlamydia trachomatis infections: a long-term prospective cohort study from 2008 to 2022The Lancet Regional Health - Europe · 2024
  9. Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based studyThe Lancet Regional Health - Europe · 2024
  10. Prevalence of dementia diagnosis in Sweden by geographical region and sociodemographic subgroups: a nationwide observational studyThe Lancet Regional Health - Europe · 2024
  11. Is the right answer always correct: between primary endpoint and clinical validity-author's replyThe Lancet Regional Health - Europe · 2024
  12. COVID-19 vaccination and birth outcomes of 186,990 women vaccinated before pregnancy: an England-wide cohort studyThe Lancet Regional Health - Europe · 2024
  13. Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational studyThe Lancet Regional Health - Europe · 2024
  14. The 25th International AIDS conference (AIDS 2024)The Lancet Regional Health - Europe · 2024
  15. Salpingectomy versus tubal occlusion in laparoscopic sterilisation (SALSTER): a national register-based randomised non-inferiority trialThe Lancet Regional Health - Europe · 2024
  16. Prenatal cell-free DNA testing of women with pregnancy-associated cancer: a retrospective cross-sectional studyThe Lancet Regional Health - Europe · 2024
  17. Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programmeThe Lancet Regional Health - Europe · 2024
  18. Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trialThe Lancet Regional Health - Europe · 2024
  19. Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and BelgiumThe Lancet Regional Health - Europe · 2024
  20. Transcranial static magnetic stimulation for amyotrophic lateral sclerosis: a bicentric, randomised, double-blind placebo-controlled phase 2 trialThe Lancet Regional Health - Europe · 2024
  21. Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort studyThe Lancet Regional Health - Europe · 2024
  22. Effectiveness of nirsevimab against RSV-bronchiolitis in paediatric ambulatory care: a test-negative case–control studyThe Lancet Regional Health - Europe · 2024
  23. Impact of a school-based food assistance program on household food insecurity in Greece, 2012–2019: a multi-year evaluation of the DIATROFI programThe Lancet Regional Health - Europe · 2024
  24. Support for smoke-free generation strategies in ItalyThe Lancet Regional Health - Europe · 2024
  25. Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015–2027): a nationwide, population-based studyThe Lancet Regional Health - Europe · 2024
  26. Cardiovascular disease in adults with a history of out-of-home care during childhood: a systematic review and meta-analysis of prospective cohort studiesThe Medicine Forum · 2024
  27. Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013–2019): a nationwide registry-based prospective studyThe Lancet Regional Health - Europe · 2024
  28. The lumbar interbody fusion trial: TLIF or PLIF for lumbar spondylolisthesis?The Lancet Regional Health - Europe · 2024
  29. How long does it take to develop a new drug?The Lancet Regional Health - Europe · 2024
  30. Randomized controlled trials for robot-assisted vs laparoscopic liver surgery: a quest on timing and endpointsThe Lancet Regional Health - Europe · 2024
  31. Contrast-enhanced mammography versus conventional imaging in women recalled from breast cancer screening (RACER trial): a multicentre, open-label, randomised controlled clinical trialThe Lancet Regional Health - Europe · 2024
  32. Impact of COVID-19 on total excess mortality and geographic disparities in Europe, 2020–2023: a spatio-temporal analysisThe Lancet Regional Health - Europe · 2024
  33. Trends in all-cause and cause-specific mortality by BMI levels in England, 2004–2019: a population-based primary care records studyThe Lancet Regional Health - Europe · 2024
  34. Less focus on symptom scales in psychiatric trials: it is time to ensure research equality between psychiatry and other medical specialitiesThe Lancet Regional Health - Europe · 2024
  35. Trends in incidence of pneumothorax in England before, during and after the COVID-19 pandemic (2017–2023): a population-based observational studyThe Lancet Regional Health - Europe · 2024
  36. Quality of life in patients with statin intolerance: a multicentre prospective registry studyThe Lancet Regional Health - Europe · 2024
  37. Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort studyThe Lancet Regional Health - Europe · 2024
  38. Suicide-related internet use among mental health patients who died by suicide in the UK: a national clinical survey with case–control analysisThe Lancet Regional Health - Europe · 2024
  39. Gender should be considered and reported in epidemiology, but why should it be measured?The Lancet Regional Health - Europe · 2024
  40. A climatic suitability indicator to support Leishmania infantum surveillance in Europe: a modelling studyThe Lancet Regional Health - Europe · 2024
  41. Healthcare costs related to respiratory syncytial virus in paediatric intensive care units in the Netherlands: a nationwide prospective observational study (the BRICK study)The Lancet Regional Health - Europe · 2024
  42. All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort studyThe Lancet Regional Health - Europe · 2024
  43. Suspected pulmonary embolism in the emergency department: over-, under- and/or mis-testing?The Lancet Regional Health - Europe · 2024
  44. Impact of a bundle of care (intravenous iron, erythropoietin and transfusion metabolic adjustment) on post-operative transfusion incidence in cardiac surgery: a single-centre, randomised, open-label, parallel-group controlled pilot trialThe Lancet Regional Health - Europe · 2024
  45. Factors associated with acceleration of clinical development for infectious diseases: a cross-sectional analysis of 10-year EMA registration dataThe Lancet Regional Health - Europe · 2024
  46. Robotic versus laparoscopic hepatectomy for liver malignancies (ROC'N'ROLL): a single-centre, randomised, controlled, single-blinded clinical trialThe Lancet Regional Health - Europe · 2024
  47. Cancer-preventing vaccination programs in prison: promoting health equity in EuropeThe Lancet Regional Health - Europe · 2024
  48. Transforaminal versus posterior lumbar interbody fusion for symptomatic single-level spondylolisthesis (LIFT): a multicentre controlled, patient blinded, randomised non-inferiority trialThe Lancet Regional Health - Europe · 2024
  49. Improving hepatocellular carcinoma surveillance in the United Kingdom: challenges and solutionsThe Lancet Regional Health - Europe · 2024
  50. Gender scores in epidemiological research: methods, advantages and implicationsThe Lancet Regional Health - Europe · 2024